Related Experiment Video
Updated: Feb 25, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Arrhythmogenic Delayed Afterdepolarizations Are Promoted by Severe Hypothermia But Not Therapeutic Hypothermia
Hidehira Fukaya1,2, Joseph S Piktel1,3, Xiaoping Wan1
1The Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University.
Insights
Severe hypothermia (SH) increases arrhythmia risk by enhancing calcium release, unlike therapeutic hypothermia (TH). TH suppresses calcium release, preventing triggered activity and associated arrhythmias.
Area of Science:
- Cardiology
- Physiology
- Biophysics
Background:
- Severe hypothermia (SH) is arrhythmogenic, but its effect on arrhythmias compared to therapeutic hypothermia (TH) is unclear.
- Hypothesized that SH, not TH, increases susceptibility to calcium-mediated arrhythmia triggers.
Purpose of the Study:
- To investigate the effects of SH and TH on calcium handling and arrhythmia triggers.
- To determine the temperature-dependent mechanisms underlying hypothermia-induced arrhythmias.
Main Methods:
- Optical mapping of spontaneous calcium release (SCR) and delayed afterdepolarizations (DADs) in canine wedge preparations at normothermia (36°C), TH (32°C), and SH (28°C).
- Evaluation of isolated myocyte calcium release kinetics and sarcoplasmic reticulum (SR) calcium content.
- Assessment of calcium spark frequency and ryanodine receptor activity.
Main Results:
- Therapeutic hypothermia (TH) suppressed multicellular SCR slope and DAD amplitude, preventing triggered activity.
- Severe hypothermia (SH) significantly increased SCR slope and DAD amplitude, leading to triggered activity.
- SH markedly increased Ca spark frequency, suggesting increased ryanodine receptor open probability, while SR Ca content remained similar between TH and SH.
Conclusions:
- Temperature-dependent alterations in calcium release explain the increased susceptibility to arrhythmia triggers in SH.
- SH increases the risk of lethal arrhythmias due to enhanced calcium release, whereas TH does not.
- Findings differentiate the arrhythmogenic potential of SH from the protective effects of TH on cardiac electrophysiology.
Background:
Severe hypothermia (SH) is known to be arrhythmogenic, but the effect of therapeutic hypothermia (TH) on arrhythmias is unclear. It is hypothesized that susceptibility to Ca-mediated arrhythmia triggers would be increased only by SH.
Methods And Results:
Spontaneous Ca release (SCR) and resultant delayed afterdepolarizations (DADs) were evaluated by optical mapping in canine wedge preparations during normothermia (N, 36℃), TH (32℃) or SH (28℃; n=8 each). The slope (amplitude/rise time) of multicellular SCR (mSCR) events, a determinant of triggered activity, was suppressed in TH (24.4±3.4%/s vs. N: 41.5±6.0%/s), but significantly higher in SH (96.3±8.1%/s) producing higher amplitude DADs in SH (35.7±1.6%) and smaller in TH (5.3±1.0% vs. N: 10.0±1.1%, all P<0.05). Triggered activity was only observed in SH. In isolated myocytes, sarcoplasmic reticulum (SR) Ca release kinetics slowed in a temperature-dependent manner, prolonging Ca transient rise time [33±3 (N) vs. 50±6 (TH) vs. 88±12 ms (SH), P<0.05], which can explain the decreased mSCR slope and DAD amplitude in TH. Although the SR Ca content was similar in TH and SH, Ca spark frequency was markedly increased only in SH, suggesting that increased ryanodine receptor open probability could explain the increased triggered activity during SH.
Conclusions:
Temperature dependence of Ca release can explain susceptibility to Ca-mediated arrhythmia triggers in SH. This may therefore explain the increased risk of lethal arrhythmia in SH, but not during TH.
Related Concept Videos
Decreased Body Temperature
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Increased Body Temperature
Homeostatic Imbalances in Body Temperature

